AbCellera Biologics Inc. ABCL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $79.21M+5.4% | $75.13M+113% | $35.32M+7.4% | $32.88M+42.2% | $23.12M-19.8% | ||
| $191M+2.2% | $186.83M+2.2% | $182.81M+8.3% | $168.75M-1.0% | $170.47M+1.9% | ||
| —— | —— | —— | —— | —— | ||
| $291.17M-0.4% | $292.23M-1.5% | $296.6M-4.8% | $311.54M-9.9% | $345.65M+0.6% | ||
| -$211.96M+2.4% | -$217.11M+16.9% | -$261.28M+6.2% | -$278.66M+13.6% | -$322.53M-2.5% | ||
| -267.6%+21.4pp | -289%+451pp | -739.7%+108pp | -847.6%+548pp | -1,395.3%-304pp | ||
| $37.82M-4.3% | $39.51M-29.9% | $56.35M-29.4% | $79.87M-28.6% | $111.9M-2.2% | ||
| -$174.15M+1.9% | -$177.6M+13.3% | -$204.93M-3.1% | -$198.79M+5.6% | -$210.63M-5.1% | ||
| -$30.19M+3.2% | -$31.18M+6.2% | -$33.25M-0.4% | -$33.12M+22.5% | -$42.76M-13.9% | ||
| -$143.96M+1.7% | -$146.41M+14.7% | -$171.68M-3.6% | -$165.67M+1.3% | -$167.87M-3.1% | ||
| -181.7%+13.1pp | -194.9%+291pp | -486%+17.9pp | -503.9%+222pp | -726.2%-161pp | ||
| -$0.48+2.0% | -$0.49+14.0% | -$0.57-3.6% | -$0.55+1.8% | -$0.56-1.8% | ||
| -$188.32M+3.4% | -$194.97M+19.8% | -$243.13M-6.2% | -$228.84M+5.3% | -$241.66M-3.1% | ||
| -237.8%+21.8pp | -259.5%+429pp | -688.3%+7.8pp | -696.1%+349pp | -1,045.5%-233pp | ||
| -$211.96M+2.4% | -$217.11M+16.9% | -$261.28M+6.2% | -$278.66M+13.6% | -$322.53M-2.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s income statement data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.